Vaxess is a company headquartered in the United States.
Vaxess develops a microarray patch platform enabling pain-free, needle-free delivery of vaccines and biologics, improving stability and accessibility by eliminating the need for refrigeration.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.